The ADC Therapeutics ticker is ADCT and is traded on the New York Stock Exchange.
May 15, 2020
Biopôle Route de la Corniche 3B 1066 Epilanges, Switzerland
View the Board of Directors here and Leadership Team here.
Davis Polk & Wardwell LLP: 450 Lexington Avenue, New York, NY 10017 Homburger AG: Hardstrasse 201, 8005 Zurich, Switzerland
ADC Therapeutics does not currently have a direct stock purchase plan. In order to buy stock, you must contact your broker.
You can contact Amanda Hamilton in the Investor Relations department at Amanda.Hamilton@adctherapeutics.com.
The Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission and its Swiss statutory annual report for the fiscal year ended December 31, 2020 are available at ir.adctherapeutics.com under “Events and Presentations”. Shareholders may receive a hard copy of the Company’s audited financial statements, or its complete Annual Report including audited financial statements, free of charge, by requesting a copy from Investor Relations at Amanda.Hamilton@adctherapeutics.com. Any requests for hard copies may be subject to a delay in mailing due to the COVID-19 pandemic.